This site is intended for healthcare professionals only

Managing emerging toxicities
with novel treatments

in myeloma

The 7th World Congress on Controversies in Multiple Myeloma (COMy 2021) Virtual Congress
Live symposium on Thursday 6 May 2021
13:30–15:00 CEST | 07:30–09:00 EDT (90 mins)
Chaired by Mohamad Mohty
Featuring speakers: Saad Usmani, Noopur Raje, Luciano Costa, Marc Labetoulle

This independent symposium, led by a faculty comprising international key opinion leaders, aims to give the target audience of hematologists, oncologists, oncology nurses, and healthcare professionals (HCPs) the necessary tools to identify and manage toxicity issues associated with new multiple myeloma treatments.

You will have the opportunity to pose questions live to the faculty.

Learning objectives

After participating in the symposium, you will be able to:

  • Identify and explain toxicity issues related to new treatments for multiple myeloma
  • Debate how to appropriately manage multiple myeloma-related cardiovascular toxicities
  • Discuss and analyze the advances in the management of cytokine-release syndrome, neurotoxicities, and ocular toxicities, caused by novel treatments like CAR-T-cell therapy and antibody–drug conjugates
Time Title Faculty
Welcome and introduction
Mohamad Mohty, France
Managing multiple myeloma-related cardiotoxicities
Saad Usmani, USA
Managing cytokine release syndrome after CAR-T cell therapy
Noopur Raj, USA
Managing neurotoxicities after CAR-T cells and T cell engagers
Luciano Costa, USA
Managing ocular adverse events after antibody drug-conjugates
Marc Labetoulle, France
Faculty discussion and audience questions
All, facilitated by Mohamad Mohty
Summary and conclusions
Mohamad Mohty, France

This program is targeted at hematologists, oncologists, oncology nurses and healthcare professionals (HCPs) in Europe, USA, Canada and Japan.


Logo for Jointly Accredited Provider Professional Continuing Education

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME.

NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

NACCME designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.


NACCME designates the live activity a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to claim your credits

To claim your credits for participating in the accredited activities, you will need to take part in the full live session, then fill out the short evaluation form at the end of the activity and complete the appropriate details.

Disclosure of relevant financial relationships

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

NACCME requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COIs are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Planning Committee

In addition to the expert faculty, NACCME and Springer Healthcare IME planners and staff include Greaton Sellers, Philly Morris-Jones, Alba Ruzafa and Marie Le Solliec. The Planning Committee have no financial relationships to disclose.

Educational grant

This program is made possible thanks to an independent educational grant from GlaxoSmithKline.